
About Neurovigil
Neurovigil is a Healthcare company based in Mountain View (United States) founded in 2007. Solution provider for analysis of brain data in medical applications. It operates in the Healthcare and Technology sectors. Neurovigil has raised $250 thousand across 3 funding rounds from investors including DFJ, Zone Ventures and Draper Frontier. Neurovigil offers products and services including iBrain Device, SPEARS Algorithm, and Dynamic Signal Processing (DSS). Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Diversified and High Tech. Its legal entity is NeuroVigil, Inc. Its competitors include Bio Rad, Quanterix and Ceribell; 2 of its 3 listed competitors have raised funding.
Company details
NeuroVigil is a neuroscience company focused on the analysis of brain signal or EEG data, which is used in numerous medical applications but is not automated. Its patent-pending and proprietary technology provides automated, and accurate reading and interpretation of EEG data, which is a window to the functioning of the brain. The technology not only automates current manual tasks, but also more than quadruples the amount of useful information obtained from current EEG data, which may lead in the future to neural signatures, or correlates of important disease states, that will be useful in early detection and diagnosis of important medical conditions. NeuroVigil is the winner of the fourth annual DFJ Venture Challenge, a business plan competition sponsored by Draper Fisher Jurvetson (DFJ), DFJ Frontier, and Zone Ventures, that awards 250,000 in seed funding to the winner.
- Headquarters Mountain View, United States
- SectorsHealthcareTechnology
- Website neurovigil.com
- Social X
- Legal Name Neurovigil, Inc
- Total Equity Funding$250K (USD)
in 3 rounds
- InvestorsDFJ
& 2 more
Products & Services of Neurovigil
Neurovigil offers a comprehensive portfolio of products and services, including iBrain Device, SPEARS Algorithm, and Dynamic Signal Processing (DSS).
Portable EEG for real-time brain activity analysis and disease detection
Software for automated EEG data processing and sleep pattern recognition
Technology for interpreting brain signals in research applications
Funding Insights of Neurovigil
Neurovigil has successfully raised a total of $250K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $250,000
- Total Rounds 3
- First Round $250,000
(May 2008)
- Investors Count 3
All 3 funding rounds of Neurovigil with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2015 | Series B | β | β | ||
| May 2011 | Series A | β | β | β | |
| May 2008 | $250,000 | Seed | β | β |
3 investors in total: 3 institutional.
Investors in Neurovigil
Neurovigil has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include DFJ, Zone Ventures and Draper Frontier.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
US focused VC firm | dfj.com | Menlo Park, United States | ||
| zonevc.com | ||||
Seed & early-stage micro VC firm investing in the US | draperfrontier.com | Los Angeles, United States |
Investor details for Neurovigil
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Neurovigil
2 people are tracked at Neurovigil (1 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Dr. Philip Low | Founder, Chairman, and CEO | Leadership |
Rebecca Brown | Proud And Fearless Member Of The Manhattan Project For The Brain™ | Team |
Complete people profiles for Neurovigil
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Neurovigil
3 dated milestones of Neurovigil across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Neurovigil is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Series B,.
Competitors of Neurovigil
Neurovigil has 3 listed competitors in our database, 2 of them funded. They include Bio Rad, Quanterix and Ceribell.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bio-rad.com | 1952 | Hercules, United States | 10 | Portfolio of products and services for life science research and clinical diagnostic markets | ||
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| ceribell.com | 2014 | Mountain View, United States | $187.52M | 218 | Portable EEG devices for point-of-care seizure diagnosis are provided. |
Detailed competitors of Neurovigil
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Neurovigil
The website of Neurovigil (neurovigil.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▲ 8.4% vs previous month
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Neurovigil (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neurovigil
Complete news archive for Neurovigil
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurovigil
Neurovigil was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Neurovigil is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Neurovigil is a funded company, having raised a total of $250K across 3 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on May 2008.
NeuroVigil is a neuroscience company focused on the analysis of brain signal or EEG data, which is used in numerous medical applications but is not automated. Its patent-pending and proprietary technology provides automated, and accurate reading and interpretation of EEG data, which is a window to the functioning of the brain. The technology not only automates current manual tasks, but also more than quadruples the amount of useful information obtained from current EEG data, which may lead in the future to neural signatures, or correlates of important disease states, that will be useful in early detection and diagnosis of important medical conditions. NeuroVigil is the winner of the fourth annual DFJ Venture Challenge, a business plan competition sponsored by Draper Fisher Jurvetson (DFJ), DFJ Frontier, and Zone Ventures, that awards 250,000 in seed funding to the winner.
Neurovigil offers iBrain Device, SPEARS Algorithm, and Dynamic Signal Processing (DSS).
Neurovigil has 3 investors. Key investors include DFJ, Zone Ventures, and Draper Frontier.
Neurovigil operates through Neurovigil, Inc.
